General Information of Drug (ID: DMWJZ8O)

Drug Name
CCP-020
Indication
Disease Entry ICD 11 Status REF
Epidermolysis bullosa EC3Z Phase 3 [1]
Cross-matching ID
TTD ID
D08KXO

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)